UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 291

Sortiert nach

Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients

Journal of clinical pharmacology, 2006-10, Vol.46 (10), p.1171-1178

2006

Volltextzugriff (PDF)

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

Infection control and hospital epidemiology, 2006-11, Vol.27 (11), p.1226

2006

Volltextzugriff (PDF)

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

Journal of clinical pharmacology, 2003-10, Vol.43 (10), p.1116-1123

2003

Volltextzugriff (PDF)

Optimizing Pharmacodynamic Target Attainment Using the MYSTIC Antibiogram: Data Collected in North America in 2002

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2464-2470

2004

Volltextzugriff (PDF)

Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic

Clinical infectious diseases, 2001-09, Vol.33 (5), p.700-705

2001

Volltextzugriff (PDF)

Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2006-02, Vol.50 (2), p.788-790

2006

Volltextzugriff (PDF)

Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations

Antimicrobial Agents and Chemotherapy, 2005-04, Vol.49 (4), p.1629-1632

2005

Volltextzugriff (PDF)

Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.672-677

1999

Volltextzugriff (PDF)

Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.1941-1947

2004

Volltextzugriff (PDF)

Cost Effect of Managing Methicillin-Resistant Staphylococcus Aureus in a Long-Term Care Facility

Journal of the American Geriatrics Society (JAGS), 2003-01, Vol.51 (1), p.10-16

2003

Volltextzugriff (PDF)

The Pharmacodynamics of Aminoglycosides

Clinical infectious diseases, 1998-07, Vol.27 (1), p.23-27

1998

Volltextzugriff (PDF)

Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs)

Journal of antimicrobial chemotherapy, 2005-09, Vol.56 (3), p.498-501

2005

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients

Journal of clinical pharmacology, 2006-01, Vol.46 (1), p.69-75

2006

Volltextzugriff (PDF)

Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1425-1434

2002

Volltextzugriff (PDF)

Pharmacodynamics of Moxifloxacin and Levofloxacin at Simulated Epithelial Lining Fluid Drug Concentrations against Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1215-1221

2004

Volltextzugriff (PDF)

Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-11, Vol.811 (2), p.225-229

2004

Volltextzugriff (PDF)

Pharmacodynamic Profile of Ertapenem against Klebsiella pneumoniae and Escherichia coli in a Murine Thigh Model

Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.276-280

2005

Volltextzugriff (PDF)

Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model

Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.188-194

2005

Volltextzugriff (PDF)

Comparison of Pharmacodynamic Target Attainment Between Healthy Subjects and Patients for Ceftazidime and Meropenem

Pharmacotherapy, 2005-07, Vol.25 (7), p.935-941

2005

Volltextzugriff (PDF)

Pharmacodynamics of Meropenem and Imipenem Against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa

Pharmacotherapy, 2004-01, Vol.24 (1), p.8-15

2004

Volltextzugriff (PDF)

Bactericidal Effect and Pharmacodynamics of Cethromycin (ABT-773) in a Murine Pneumococcal Pneumonia Model

Antimicrobial Agents and Chemotherapy, 2002-10, Vol.46 (10), p.3185-3192

2002

Volltextzugriff (PDF)

Pharmacodynamics and Pharmacokinetics of Levofloxacin

Chemotherapy (Basel), 2000-01, Vol.46 (Suppl 1), p.6-14

2000

Volltextzugriff (PDF)

Pharmacodynamic Assessment of Gatifloxacin against Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2001-07, Vol.45 (7), p.2092-2097

2001

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

Journal of antimicrobial chemotherapy, 2005-08, Vol.56 (2), p.388-395

2005

Volltextzugriff (PDF)

Pharmacokinetic Profile of Meropenem, Administered at 500 Milligrams Every 8 Hours, in Plasma and Cantharidin-Induced Skin Blister Fluid

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1771-1773

2003

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Englisch
(291)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(224)
Humans
(166)
Pharmacology & Pharmacy
(165)
Biological And Medical Sciences
(142)
Medical Sciences
(141)
Pharmacology. Drug Treatments
(133)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(121)
Antibacterial Agents
(101)
Microbiology
(97)
Female
(91)
Infectious Diseases
(78)
Male
(73)
Animals
(66)
Microbial Sensitivity Tests
(62)
Adult
(61)
Anti-Bacterial Agents - Pharmacology
(39)
Middle Aged
(38)
Anti-Bacterial Agents - Pharmacokinetics
(37)
Anti-Bacterial Agents - Therapeutic Use
(30)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

Optimizing Pharmacodynamic Target Attainment Using the MYSTIC Antibiogram: Data Collected in North America in 2002

Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic

Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects

Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations

Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection

Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula

Cost Effect of Managing Methicillin-Resistant Staphylococcus Aureus in a Long-Term Care Facility

The Pharmacodynamics of Aminoglycosides

Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs)

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients

Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia

Pharmacodynamics of Moxifloxacin and Levofloxacin at Simulated Epithelial Lining Fluid Drug Concentrations against Streptococcus pneumoniae

Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography

Pharmacodynamic Profile of Ertapenem against Klebsiella pneumoniae and Escherichia coli in a Murine Thigh Model

Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model

Comparison of Pharmacodynamic Target Attainment Between Healthy Subjects and Patients for Ceftazidime and Meropenem

Pharmacodynamics of Meropenem and Imipenem Against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa

Bactericidal Effect and Pharmacodynamics of Cethromycin (ABT-773) in a Murine Pneumococcal Pneumonia Model

Pharmacodynamics and Pharmacokinetics of Levofloxacin

Pharmacodynamic Assessment of Gatifloxacin against Streptococcus pneumoniae

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

Pharmacokinetic Profile of Meropenem, Administered at 500 Milligrams Every 8 Hours, in Plasma and Cantharidin-Induced Skin Blister Fluid

Suchergebnisse filtern